OIG Reports That Diabetes Test Suppliers Improperly Billed Medicare

False Claims Act, Whistleblower

In a recent report, the Office of Inspector General for the U.S. Department of Health and Human Services found that suppliers improperly billed Medicare for more expensive diabetes test strips. The study focused on practices that included (1) improperly billing mail...

OIG Study Finds That Medicare Contractors Lacked Controls To Prevent Millions In Improper Payments For Blood-Glucose Test Strips

False Claims Act, Whistleblower

The Office of Inspector General (OIG) recently conducted a review of contractors that process claims for home blood-glucose test strip and lancet supplies.  Medicare Part B covers test strips and lancets prescribed by physicians for diabetics.  This coverage depends...

Ex-Bayer Salesman Wins Award In FCA Retaliation Suit

False Claims Act, Whistleblower

Ex-Bayer Salesman Wins Award In FCA Retaliation Suit By Keith Goldberg Law360, New York (November 05, 2012, 3:52 PM ET) — An Arkansas federal jury on Friday awarded a former Bayer Corp. sales representative nearly $900,000 after finding that the company fired...

Missouri Hospital System Agrees to Pay $9.3 Million to Resolve False Claims Act and Stark Law Violations

False Claims Act, Whistleblower

Department of Justice  Office of Public Affairs FOR IMMEDIATE RELEASE Monday, November 5, 2012  Missouri Hospital System Agrees to Pay $9.3 Million to Resolve False Claims Act and Stark Law Violations Hospital Allegedly Improperly Compensated Physicians for Referrals...

Pfizer discloses $491M charge for Rapamune marketing settlement

Whistleblower

Pfizer has disclosed a $491 million charge for a Rapamune marketing settlement, fiercepharma.com reports, citing Dow Jones. The company made a deal with the US Justice Department to resolve the long-standing probe, which Pfizer inherited when it bought Wyeth in 2009....